NCT01901614

Brief Summary

The purpose of this study is to determine if a new procedure, called laser-assisted lamellar anterior keratoplasty (LALAK), can achieve the same level of vision with a lower risk of potential complications after surgery compared to another corneal transplant procedure. The current procedure is called Intralase-enabled keratoplasty (IEK) and replaces the entire cornea. The LALAK procedure involves transplanting only the top layers of the cornea instead of the entire cornea. Only one eye will have this experimental procedure performed. If both eyes need to have surgery your doctor will help you decide on the best non-study option for your other eye.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 2, 2013

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 17, 2013

Completed
15 days until next milestone

Study Start

First participant enrolled

August 1, 2013

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2017

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

January 23, 2019

Completed
Last Updated

January 23, 2019

Status Verified

January 1, 2019

Enrollment Period

4.1 years

First QC Date

July 2, 2013

Results QC Date

October 19, 2018

Last Update Submit

January 16, 2019

Conditions

Keywords

KeratoconusCorneal OpacityKeratoplasty

Outcome Measures

Primary Outcomes (1)

  • Does LALAK Achieve the Same Level of Post-operative BSCVA as IEK.

    The primary goal of the trial is to determine if LALAK can achieve the same level of postoperative Best Spectacle Corrected Visual Acuity (BSCVA) guided by OCT as IEK. The BSCVA will be measured using a clinic Snellen chart and recorded in the typical Snellen fraction (20/xx) in feet. This will be converted to logMAR form for statistical analysis.

    24 months

Study Arms (2)

LALAK

EXPERIMENTAL

laser-assisted lamellar anterior keratoplasty. Optical Coherence Tomography, femtosecond laser, topical anesthesia, and Retrobulbar Block or General Anesthesia will be used.

Procedure: LALAKDevice: optical coherence tomography (OCT)Drug: Topical AnesthesiaDevice: femtosecond laser

IEK

ACTIVE COMPARATOR

Intralase-enabled keratoplasty. Femtosecond laser and Retrobulbar Block or General Anesthesia will be used.

Procedure: IEKDrug: Retrobulbar Block or General AnesthesiaDevice: femtosecond laser

Interventions

LALAKPROCEDURE

1. A "dovetail" shaped cut will be made on the graft using a femtosecond laser at the eye bank. The cut depth will be proportional to the central stromal thickness of the graft. This graft will be separated from stromal bed by eye bank personnel for examination of the cut surface. High-quality graft will be replaced in preservation medium and shipped to the surgeon prior to surgery. 2. The host cornea will receive femtosecond laser cut consisting of a shallow lamellar cut with angled side cut to match the dovetail graft in a tongue-in-groove fashion. The femtosecond laser treatments will be performed under topical anesthesia in the laser suite. The femtosecond laser is an FDA-approved device for use in this indication (corneal transplantation including lamellar keratoplasty). A protective eye shield is placed over the eye. The graft will be sutured into the host bed.

LALAK
IEKPROCEDURE

1. A full thickness graft will be prepared at the eye bank with zigzag side cuts prepared with a femtosecond laser. The graft is separated from the rim, replaced in the preservation medium, and shipped to the surgeon prior to the surgery. 2. In the laser suite, the host cornea will be cut with the femtosecond laser with zigzag side cuts leaving a 70-100 micron bridge. A protective eye shield is placed over the eye. The graft will be sutured into the host bed.

IEK

OCT will be used to guide the depth of the graft and donor dissections.

LALAK

The femtosecond laser system to be used in this study for host cornea preparation will be the Intralase FS system (iFS, AMO, Inc., Santa Ana, CA). The iFS is FDA-approved for corneal surgery including full thickness and lamellar keratoplasty. Eye banks use earlier versions of the Intralase system which are also FDA approved for this indication.

IEKLALAK

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Eyes with keratoconus that cannot be adequately or safely corrected with spectacles, contact lens or excimer laser surface ablation. The cornea must have healthy endothelium (endothelial cell density \> 1,500/mm2).

You may not qualify if:

  • Preoperative corneal thickness less than 400 microns.
  • Corneal edema
  • Central guttata
  • Inability to give informed consent.
  • Inability to maintain stable fixation for OCT imaging.
  • Inability to commit to required visits to complete the study.
  • Eyes with concurrent cataract, retinal diseases, glaucoma, or other eye conditions that may limit the visual outcome after surgery.
  • Patients with severe collagen vascular diseases or ocular surface disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Casey Eye Institute, Oregon Health & Science University

Portland, Oregon, 97239, United States

Location

Related Links

MeSH Terms

Conditions

Corneal OpacityKeratoconus

Interventions

Anesthesia, GeneralTomography, Optical CoherenceAnesthesia

Condition Hierarchy (Ancestors)

Corneal DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

Anesthesia and AnalgesiaTomography, OpticalOptical ImagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomographyInvestigative Techniques

Results Point of Contact

Title
David Huang, MD, PhD
Organization
Oregon Health & Science University

Study Officials

  • Winston Chamberlain, MD, PhD

    Oregon Health and Science University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Winston Chamberlain, MD, PhD, Assistant Professor of Ophthalmology

Study Record Dates

First Submitted

July 2, 2013

First Posted

July 17, 2013

Study Start

August 1, 2013

Primary Completion

August 31, 2017

Study Completion

August 31, 2017

Last Updated

January 23, 2019

Results First Posted

January 23, 2019

Record last verified: 2019-01

Locations